| SPDR金 |
Jefferies Financial Group Inc. |
减持 |
-10409500 |
806.43万股 |
0.03% |
好仓 |
2023-11-17 |
| 药明合联 |
WuXi Biologics (Cayman) Inc. |
增持 |
600000000 |
60000.00万股 |
0.51% |
好仓 |
2023-11-17 |
| 药明合联 |
李锦才 |
增持 |
32455840 |
3245.58万股 |
0.03% |
好仓 |
2023-11-17 |
| 堃博医疗-B |
Broncus Biomedical Limited |
减持 |
-21956727 |
2178.52万股 |
0.04% |
好仓 |
2023-11-17 |
| 堃博医疗-B |
Dinova Healthcare Gamma Fund (USD), L.P. |
减持 |
-21956727 |
2178.52万股 |
0.04% |
好仓 |
2023-11-17 |
| 堃博医疗-B |
Dinova Venture Partners GP III, L.P. |
减持 |
-21956727 |
2616.52万股 |
0.05% |
好仓 |
2023-11-17 |
| 堃博医疗-B |
Dinova Capital Limited |
减持 |
-21956727 |
2616.52万股 |
0.05% |
好仓 |
2023-11-17 |
| 堃博医疗-B |
Xin Nuo Tong Investment Limited |
减持 |
-21956727 |
4983.52万股 |
0.09% |
好仓 |
2023-11-17 |
| 堃博医疗-B |
Qiming Corporate GP IV, Ltd. |
增持 |
6133164 |
8754.60万股 |
0.17% |
好仓 |
2023-11-17 |
| 堃博医疗-B |
Qiming GP IV, L.P. |
增持 |
5945440 |
8735.82万股 |
0.17% |
好仓 |
2023-11-17 |
| 堃博医疗-B |
Qiming Venture Partners IV, L.P. |
增持 |
5945440 |
8735.82万股 |
0.17% |
好仓 |
2023-11-17 |
| 堃博医疗-B |
訾振军 |
减持 |
-21956727 |
9975.15万股 |
0.19% |
好仓 |
2023-11-17 |
| 国美零售 |
黄光裕 |
减持 |
-607000000 |
758691.86万股 |
0.16% |
好仓 |
2023-11-17 |
| 国美零售 |
杜鹃 |
减持 |
-607000000 |
758691.86万股 |
0.16% |
好仓 |
2023-11-17 |
| 东方电气 |
JPMorgan Chase & Co. |
减持 |
-9667355 |
1135.24万股 |
0.03% |
好仓 |
2023-11-17 |
| 建业新生活 |
JPMorgan Chase & Co. |
减持 |
-70802653 |
627.10万股 |
0.00% |
好仓 |
2023-11-17 |
| 中国同辐 |
UBS Group AG |
减持 |
-2477932 |
170.81万股 |
0.02% |
好仓 |
2023-11-17 |
| 零跑汽车 |
傅利泉 |
减持 |
-45000000 |
12851.78万股 |
0.58% |
好仓 |
2023-11-17 |
| 零跑汽车 |
陈爱玲 |
减持 |
-45000000 |
12851.78万股 |
0.58% |
好仓 |
2023-11-17 |
| 知乎-W |
MO Holding Ltd |
减持 |
-317832 |
1814.56万股 |
1.00% |
好仓 |
2023-11-17 |
